메뉴 건너뛰기




Volumn 19, Issue 21, 2012, Pages 3578-3604

Sulfonyl group-containing compounds in the design of potential drugs for the treatment of diabetes and its complications

Author keywords

Activators; Diabetes; Diabetic complications; Glucose metabolism; Inhibitors; Insulin secretion resistance; Sulfonyl group

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR; 2 CYCLOHEXYL 1 (4 METHANESULFONYLPHENYL)CYCLOPROPANECARBOXYLIC ACID 2 THIAZOLYLAMIDE; ALDEHYDE REDUCTASE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE INHIBITOR; ENZYME ACTIVATOR; ENZYME INHIBITOR; GHRELIN RECEPTOR; GHRELIN RECEPTOR BLOCKING AGENT; GLUCOKINASE; GLUCOKINASE ACTIVATOR; GLUCOSE; HORMONE RECEPTOR BLOCKING AGENT; INSULIN; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR TYROSINE KINASE ACTIVATOR; KOTALANOL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) INHIBITOR; QUINAZOLINE DERIVATIVE; RO 281675; SALACINOL; SALCINOL; SULFONAMIDE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84863753093     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712801323225     Document Type: Review
Times cited : (118)

References (238)
  • 1
    • 57349132464 scopus 로고    scopus 로고
    • Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme
    • Humljan, J.; Kotnik, M.; Contreras-Martel, C; Blanot, D.; Urleb, U.; Dessen, A.a.; S olmajer, T.; Gobec, S. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme. J. Med. Chem., 2008, 51 (23), 7486-7494.
    • (2008) J. Med. Chem. , vol.51 , Issue.23 , pp. 7486-7494
    • Humljan, J.1    Kotnik, M.2    Contreras-Martel, C.3    Blanot, D.4    Urleb, U.5    Dessen, A.A.6    Olmajer T, S.7    Gobec, S.8
  • 2
    • 3142617909 scopus 로고    scopus 로고
    • Sulfonyl-Containing Aldophosphamide Analogues as Novel Anticancer Prodrugs Targeted against Cyclophosphamide-Resistant Tumor Cell Lines
    • Jain, M.; Fan, J.; Baturay, N.Z.; Kwon, C.-H. Sulfonyl-Containing Aldophosphamide Analogues as Novel Anticancer Prodrugs Targeted against Cyclophosphamide-Resistant Tumor Cell Lines. J. Med. Chem., 2004, 47 (15), 3843-3852.
    • (2004) J. Med. Chem. , vol.47 , Issue.15 , pp. 3843-3852
    • Jain, M.1    Fan, J.2    Baturay, N.Z.3    Kwon, C.-H.4
  • 3
    • 41149177054 scopus 로고    scopus 로고
    • Inhibition of Carbonic Anhydrases with Glycosyltriazole Benzene Sulfonamides
    • Wilkinson, B.L.; Innocenti, A.; Vullo, D.; Supuran, C.T; Poulsen, S.-A. Inhibition of Carbonic Anhydrases with Glycosyltriazole Benzene Sulfonamides. J. Med. Chem., 2008, 51 (6), 1945-1953.
    • (2008) J. Med. Chem. , vol.51 , Issue.6 , pp. 1945-1953
    • Wilkinson, B.L.1    Innocenti, A.2    Vullo, D.3    Supuran, C.T.4    Poulsen, S.-A.5
  • 4
    • 79960622162 scopus 로고    scopus 로고
    • Discovery and Optimization of Sulfonyl Acrylonitriles as Selective, Covalent Inhibitors of Protein Phosphatase Methylesterase-1
    • Bachovchin, D.A.; Zuhl, A.M.; Speers, A.E.; Wolfe, M.R.; Weerapana, E.; Brown, S.J.; Rosen, H.; Cravatt, B.F. Discovery and Optimization of Sulfonyl Acrylonitriles as Selective, Covalent Inhibitors of Protein Phosphatase Methylesterase-1. J. Med. Chem., 2011, 54 (14), 5229-5236.
    • (2011) J. Med. Chem. , vol.54 , Issue.14 , pp. 5229-5236
    • Bachovchin, D.A.1    Zuhl, A.M.2    Speers, A.E.3    Wolfe, M.R.4    Weerapana, E.5    Brown, S.J.6    Rosen, H.7    Cravatt, B.F.8
  • 5
    • 77949489197 scopus 로고    scopus 로고
    • Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents
    • Alqasoumi, S.I.; Al-Taweel, A.M.; Alafeefy, A.M.; Ghorab, MM.; Noaman, E. Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents. Eur. J. Med. Chem., 2010, 45 (5), 1849-1853.
    • (2010) Eur. J. Med. Chem. , vol.45 , Issue.5 , pp. 1849-1853
    • Alqasoumi, S.I.1    Al-Taweel, A.M.2    Alafeefy, A.M.3    Ghorab, M.M.4    Noaman, E.5
  • 6
    • 42149114451 scopus 로고    scopus 로고
    • Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides
    • Supuran, C.T. Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides. Curr. Pharm. Des., 2008, 14 (7), 641-648.
    • (2008) Curr. Pharm. Des. , vol.14 , Issue.7 , pp. 641-648
    • Supuran, C.T.1
  • 7
    • 33747474452 scopus 로고    scopus 로고
    • Binding of Sulfonyl-Containing Arylalkylamines at Human 5-HT6 Serotonin Receptors
    • Sikazwe, D.; Bondarev, M.L.; Dukat, M.; Rangisetty, J.B.; Roth, B.L.; Glennon, R.A. Binding of Sulfonyl-Containing Arylalkylamines at Human 5-HT6 Serotonin Receptors. J. Med. Chem., 2006, 49 (17), 5217-5225.
    • (2006) J. Med. Chem. , vol.49 , Issue.17 , pp. 5217-5225
    • Sikazwe, D.1    Bondarev, M.L.2    Dukat, M.3    Rangisetty, J.B.4    Roth, B.L.5    Glennon, R.A.6
  • 8
    • 0038460888 scopus 로고    scopus 로고
    • Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7)
    • Glennon, R.A. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). J. Med. Chem., 2003, 46 (14), 2795-2812.
    • (2003) J. Med. Chem. , vol.46 , Issue.14 , pp. 2795-2812
    • Glennon, R.A.1
  • 9
    • 64349124929 scopus 로고    scopus 로고
    • Structure and modeling in the design of ß-and y-secretase inhibitors
    • Holloway, M.K.; Hunt, P.; McGaughey, G.B. Structure and modeling in the design of ß-and y-secretase inhibitors. Drug Dev. Res., 2009, 70 (2), 70-93.
    • (2009) Drug Dev. Res. , vol.70 , Issue.2 , pp. 70-93
    • Holloway, M.K.1    Hunt, P.2    McGaughey, G.B.3
  • 11
    • 62249167406 scopus 로고    scopus 로고
    • Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease
    • Silvestri, R. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease. Med. Res. Rev., 2009, 29 (2), 295-338.
    • (2009) Med. Res. Rev. , vol.29 , Issue.2 , pp. 295-338
    • Silvestri, R.1
  • 15
    • 0029957413 scopus 로고    scopus 로고
    • Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
    • Hanefeld, M.; Fischer, S.; Julius, U.; Schulze, J.; Schwanebeck, U.; Schmechel, H.; Ziegelasch, H.J.; Lindner, J. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia, 1996, 39 (12), 1577-1583.
    • (1996) Diabetologia , vol.39 , Issue.12 , pp. 1577-1583
    • Hanefeld, M.1    Fischer, S.2    Julius, U.3    Schulze, J.4    Schwanebeck, U.5    Schmechel, H.6    Ziegelasch, H.J.7    Lindner, J.8
  • 18
    • 0029050649 scopus 로고
    • Inhibition of starch digestion by {alpha}-amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards the growth of rats
    • Pusztai, A.; Grant, G.; Duguid, T.; Brown, D.S.; Peumans, W.J.; van Damme, E.J.M.; Bardocz, S. Inhibition of starch digestion by {alpha}-amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards the growth of rats. J. Nutr, 1995, 125 (6), 1554-1562.
    • (1995) J. Nutr , vol.125 , Issue.6 , pp. 1554-1562
    • Pusztai, A.1    Grant, G.2    Duguid, T.3    Brown, D.S.4    Peumans, W.J.5    Van Damme, E.J.M.6    Bardocz, S.7
  • 20
    • 60249093549 scopus 로고    scopus 로고
    • Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
    • van de Laar, F.A. Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc Health Risk Manag, 2008, 4 (6), 1189-1195.
    • (2008) Vasc Health Risk Manag , vol.4 , Issue.6 , pp. 1189-1195
    • Van De Laar, F.A.1
  • 21
    • 80051783296 scopus 로고    scopus 로고
    • Cinnamon extract inhibits.alpha.-glucosidase activity and dampens postprandial glucose excursion in diabetic rats
    • doi: 10.1186/1743-7075-1188-1146
    • Shihabudeen H., M.S.; Priscilla D., H.; Thirumurugan, K. Cinnamon extract inhibits.alpha.-glucosidase activity and dampens postprandial glucose excursion in diabetic rats. Nutr. Metab., 2011, 8 (1), doi: 10.1186/1743-7075-1188-1146
    • (2011) Nutr. Metab. , vol.8 , Issue.1
    • Shihabudeen, H.M.S.1    Priscilla, D.H.2    Thirumurugan, K.3
  • 22
    • 0031722553 scopus 로고    scopus 로고
    • A potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata
    • Yoshikawa, M.; Murakami, T.; Yashiro, K.; Matsuda, H. Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata. Chem. Pharm. Bull, 1998, 46 (8), 1339-1340.
    • (1998) Chem. Pharm. Bull , vol.46 , Issue.8 , pp. 1339-1340
    • Yoshikawa, M.1    Murakami, T.2    Yashiro, K.3    Kotalanol, M.H.4
  • 23
    • 0035821342 scopus 로고    scopus 로고
    • Glycosidase Inhibition by Cyclic Sulfonium Compounds
    • Yuasa, H.; Takada, J.; Hashimoto, H. Glycosidase Inhibition by Cyclic Sulfonium Compounds. Bioorg. Med. Chem. Lett, 2001, 11 (9), 1137-1139.
    • (2001) Bioorg. Med. Chem. Lett , vol.11 , Issue.9 , pp. 1137-1139
    • Yuasa, H.1    Takada, J.2    Hashimoto, H.3
  • 24
    • 34247333428 scopus 로고    scopus 로고
    • Biological evaluation of de-O-sulfonated analogs of salacinol, the role of sulfate anion in the side chain on the a-glucosidase inhibitory activity
    • Tanabe, G.; Yoshikai, K.; Hatanaka, T.; Yamamoto, M.; Shao, Y; Minematsu, T.; Muraoka, O.; Wang, T.; Matsuda, H.; Yoshikawa, M. Biological evaluation of de-O-sulfonated analogs of salacinol, the role of sulfate anion in the side chain on the a-glucosidase inhibitory activity. Bioorg. Med. Chem., 2007, 15 (11), 3926-3937.
    • (2007) Bioorg. Med. Chem. , vol.15 , Issue.11 , pp. 3926-3937
    • Tanabe, G.1    Yoshikai, K.2    Hatanaka, T.3    Yamamoto, M.4    Shao, Y.5    Minematsu, T.6    Muraoka, O.7    Wang, T.8    Matsuda, H.9    Yoshikawa, M.10
  • 26
    • 75849129602 scopus 로고    scopus 로고
    • Synthesis and evaluation of the [alpha]-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives
    • Wang, S.; Yan, J.; Wang, X.; Yang, Z.; Lin, F.; Zhang, T. Synthesis and evaluation of the [alpha]-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives. Eur. J. Med. Chem., 2010, 45 (3), 1250-1255.
    • (2010) Eur. J. Med. Chem. , vol.45 , Issue.3 , pp. 1250-1255
    • Wang, S.1    Yan, J.2    Wang, X.3    Yang, Z.4    Lin, F.5    Zhang, T.6
  • 27
    • 64249101080 scopus 로고    scopus 로고
    • Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates
    • Luiken, J.J.F.P; Niessen, H.E.C.; Coort, S.L.M.; Hoebers, N; Coumans, W.A.; Schwenk, R.W.; Bonen, A.; Glatz, J.F.C. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates. Biochem. J., 2009, 419 (2), 447-455.
    • (2009) Biochem. J. , vol.419 , Issue.2 , pp. 447-455
    • Luiken, J.J.F.P.1    Niessen, H.E.C.2    Coort, S.L.M.3    Hoebers, N.4    Coumans, W.A.5    Schwenk, R.W.6    Bonen, A.7    Glatz, J.F.C.8
  • 28
    • 0018864840 scopus 로고
    • Regulation of hepatic fatty acid oxidation and ketone body production
    • McGarry, J.D.; Foster, D.W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem., 1980, 49, 395-420.
    • (1980) Annu. Rev. Biochem. , vol.49 , pp. 395-420
    • McGarry, J.D.1    Foster, D.W.2
  • 29
    • 0024503204 scopus 로고
    • Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase
    • McGarry, J.D.; Woeltje, K.F.; Kuwajima, M.; Foster, D.W. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab. Rev, 1989, 5 (3), 271-284.
    • (1989) Diabetes Metab. Rev , vol.5 , Issue.3 , pp. 271-284
    • McGarry, J.D.1    Woeltje, K.F.2    Kuwajima, M.3    Foster, D.W.4
  • 30
    • 0021024932 scopus 로고
    • Carnitine-metabolism and functions
    • Bremer, J. Carnitine-metabolism and functions. Physiol. Rev, 1983, 63 (4), 1420-1480.
    • (1983) Physiol. Rev , vol.63 , Issue.4 , pp. 1420-1480
    • Bremer, J.1
  • 31
    • 0031043030 scopus 로고    scopus 로고
    • The mitochondrial carnitine palmitoyltransferase system. from concept to molecular analysis
    • McGarry, J.D.; Brown, N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem., 1997, 244 (1), 1-14.
    • (1997) Eur. J. Biochem. , vol.244 , Issue.1 , pp. 1-14
    • McGarry, J.D.1    Brown, N.F.2
  • 32
    • 0028091713 scopus 로고
    • Use of a selective inhibitor of liver carnitine palmitoyltransferase i (CPT I) allows quantification of its contribution to total CPT i activity in rat heart. Evidence that the dominant cardiac CPT i isoform is identical to the skeletal muscle enzyme
    • Weis, B.C.; Cowan, A.T.; Brown, N; Foster, D.W.; McGarry, J.D. Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J. Biol. Chem., 1994, 269 (42), 26443-26448.
    • (1994) J. Biol. Chem. , vol.269 , Issue.42 , pp. 26443-26448
    • Weis, B.C.1    Cowan, A.T.2    Brown, N.3    Foster, D.W.4    McGarry, J.D.5
  • 33
    • 0031771423 scopus 로고    scopus 로고
    • Synthesis of 2-[6-(2, 4-Dinitrophenoxy)hexyl]oxiranecarboxylic acid: A selective carnitine palmitoyltransferase-1 inhibitor
    • Hutchison, T.L.; Brouillette, W.J. Synthesis of 2-[6-(2, 4-Dinitrophenoxy)hexyl]oxiranecarboxylic acid: A selective carnitine palmitoyltransferase-1 inhibitor. Bioorg. Med. Chem., 1998, 6 (11), 2133-2138.
    • (1998) Bioorg. Med. Chem. , vol.6 , Issue.11 , pp. 2133-2138
    • Hutchison, T.L.1    Brouillette, W.J.2
  • 37
    • 0026590484 scopus 로고
    • Pathogenesis of NIDDM: A balanced overview
    • DeFronzo, R.A.; Bonadonna, R.C.; Ferranini, E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care, 1992, 15 (3), 318-368.
    • (1992) Diabetes Care , vol.15 , Issue.3 , pp. 318-368
    • Defronzo, R.A.1    Bonadonna, R.C.2    Ferranini, E.3
  • 38
    • 0023189066 scopus 로고
    • Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin- dependent diabetic individuals
    • Golay, A.; Swislocki, A.L.M.; Chen, Y.D.; Reaven, G.M. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism., 1987, 36 (7), 692-696.
    • (1987) Metabolism. , vol.36 , Issue.7 , pp. 692-696
    • Golay, A.1    Swislocki, A.L.M.2    Chen, Y.D.3    Reaven, G.M.4
  • 39
    • 0026721574 scopus 로고
    • Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus
    • Foley, J.E. Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus. Diabetes Care, 1992, 15 (6), 773-784.
    • (1992) Diabetes Care , vol.15 , Issue.6 , pp. 773-784
    • Foley, J.E.1
  • 40
    • 0031936058 scopus 로고    scopus 로고
    • Carnitine Palmitoyltransferase: A Viable Target for the Treatment of NIDDM?
    • Anderson, R. Carnitine Palmitoyltransferase: A Viable Target for the Treatment of NIDDM? Curr. Pharm. Des., 1998, 4 (1), 1-16.
    • (1998) Curr. Pharm. Des. , vol.4 , Issue.1 , pp. 1-16
    • Anderson, R.1
  • 41
    • 0036092239 scopus 로고    scopus 로고
    • Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
    • McGarry, J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diatetes, 2002, 51 (1), 7-18.
    • (2002) Diatetes , vol.51 , Issue.1 , pp. 7-18
    • McGarry, J.D.1
  • 42
    • 0029862741 scopus 로고    scopus 로고
    • Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase i (M-CPT I) M-CPT i is the predominant CPT i isoform expressed in both white (epididymal) and brown adipocytes
    • Esser, V.; Brown, N.; Cowan, A.T.; Foster, D.W.; McGarry, J.D. Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase I (M-CPT I). M-CPT I is the predominant CPT I isoform expressed in both white (epididymal) and brown adipocytes. J. Biol. Chem., 1996, 271 (12), 6972-6977.
    • (1996) J. Biol. Chem. , vol.271 , Issue.12 , pp. 6972-6977
    • Esser, V.1    Brown, N.2    Cowan, A.T.3    Foster, D.W.4    McGarry, J.D.5
  • 43
    • 0024401731 scopus 로고
    • Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction
    • Bressler, R.; Gay, R.; Copeland, J.G.; Bahl, J.J.; Bedotto, J.; Goldman, S. Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction. Life Sci., 1989, 44 (25), 1897-1906.
    • (1989) Life Sci. , vol.44 , Issue.25 , pp. 1897-1906
    • Bressler, R.1    Gay, R.2    Copeland, J.G.3    Bahl, J.J.4    Bedotto, J.5    Goldman, S.6
  • 48
    • 0030067124 scopus 로고    scopus 로고
    • Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm
    • Matschinsky, F.M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes, 1996, 45 (2), 223-241.
    • (1996) Diabetes , vol.45 , Issue.2 , pp. 223-241
    • Matschinsky, F.M.1
  • 49
    • 0031892853 scopus 로고    scopus 로고
    • Pancreatic beta-cell glucokinase: Closing the gap between theoretical concepts and experimental realities
    • Matschinsky, F.M.; Glaser, B.; Magnuson, M.A. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes, 1998, 47 (3), 307-315.
    • (1998) Diabetes , vol.47 , Issue.3 , pp. 307-315
    • Matschinsky, F.M.1    Glaser, B.2    Magnuson, M.A.3
  • 50
    • 1542791635 scopus 로고    scopus 로고
    • Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase
    • Kamata, K.; Mitsuya, M.; Nishimura, T.; Eiki, J.I.; Nagata, Y. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure, 2004, 12 (3), 429-438.
    • (2004) Structure , vol.12 , Issue.3 , pp. 429-438
    • Kamata, K.1    Mitsuya, M.2    Nishimura, T.3    Eiki, J.I.4    Nagata, Y.5
  • 51
    • 33745043238 scopus 로고    scopus 로고
    • Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy
    • Guertin, K.R.; Grimsby, J. Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy. Curr. Med. Chem., 2006, 13 (15), 1839-1843.
    • (2006) Curr. Med. Chem. , vol.13 , Issue.15 , pp. 1839-1843
    • Guertin, K.R.1    Grimsby, J.2
  • 52
    • 39049086785 scopus 로고    scopus 로고
    • Glucokinase activators in diabetes management
    • Coghlan, M.; Leighton, B. Glucokinase activators in diabetes management. Exp. Opin. Invest. Drugs, 2008, 17 (2), 145-167.
    • (2008) Exp. Opin. Invest. Drugs , vol.17 , Issue.2 , pp. 145-167
    • Coghlan, M.1    Leighton, B.2
  • 53
    • 48049120189 scopus 로고    scopus 로고
    • Glucokinase activators as new type 2 diabetes therapeutic agents
    • Sarabu, R.; Berthel, S.J.; Kester, R.F.; Tilley, J.W. Glucokinase activators as new type 2 diabetes therapeutic agents. Exp. Opin. Ther. Patents, 2008, 18 (7), 759-768.
    • (2008) Exp. Opin. Ther. Patents , vol.18 , Issue.7 , pp. 759-768
    • Sarabu, R.1    Berthel, S.J.2    Kester, R.F.3    Tilley, J.W.4
  • 58
    • 77953131053 scopus 로고    scopus 로고
    • Design synthesis, and pharmacological evaluation of N-(4-mono and 4, 5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators
    • Li, F.; Zhu, Q.; Zhang, Y.; Feng, Y.; Leng, Y.; Zhang, A. Design, synthesis, and pharmacological evaluation of N-(4-mono and 4, 5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators. Bioorg. Med. Chem., 2010, 18 (11), 3875-3884.
    • (2010) Bioorg. Med. Chem. , vol.18 , Issue.11 , pp. 3875-3884
    • Li, F.1    Zhu, Q.2    Zhang, Y.3    Feng, Y.4    Leng, Y.5    Zhang, A.6
  • 69
    • 0033540056 scopus 로고    scopus 로고
    • Ghrelin is a growth-hormone-releasing acylated peptide from stomach
    • Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402 (6762), 656-660.
    • (1999) Nature , vol.402 , Issue.6762 , pp. 656-660
    • Kojima, M.1    Hosoda, H.2    Date, Y.3    Nakazato, M.4    Matsuo, H.5    Kangawa, K.6
  • 70
    • 0034687376 scopus 로고    scopus 로고
    • Ghrelin induces adiposity in rodents
    • Tschop, M.; Smiley, D.L.; Heiman, M.L. Ghrelin induces adiposity in rodents. Nature, 2000, 407 (6806), 908-913.
    • (2000) Nature , vol.407 , Issue.6806 , pp. 908-913
    • Tschop, M.1    Smiley, D.L.2    Heiman, M.L.3
  • 73
    • 75849131328 scopus 로고    scopus 로고
    • Roles of Gastrointestinal and Adipose Tissue Peptides in Childhood Obesity and Changes after Weight Loss Due to Lifestyle Intervention
    • Roth, C.L.; Reinehr, T. Roles of Gastrointestinal and Adipose Tissue Peptides in Childhood Obesity and Changes After Weight Loss Due to Lifestyle Intervention. Arch. Pediatr. Adolesc. Med., 2010, 164 (2), 131-138.
    • (2010) Arch. Pediatr. Adolesc. Med. , vol.164 , Issue.2 , pp. 131-138
    • Roth, C.L.1    Reinehr, T.2
  • 82
    • 0026021161 scopus 로고
    • Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
    • DeFronzo, R.A.; Ferrannini, E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 1991, 14 (3), 173-194.
    • (1991) Diabetes Care , vol.14 , Issue.3 , pp. 173-194
    • Defronzo, R.A.1    Ferrannini, E.2
  • 83
    • 0024511329 scopus 로고
    • Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM
    • Consoli, A.; Nurjhan, N.; Capani, F.; Gerich, J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes, 1989, 38 (5), 550-557.
    • (1989) Diabetes , vol.38 , Issue.5 , pp. 550-557
    • Consoli, A.1    Nurjhan, N.2    Capani, F.3    Gerich, J.4
  • 84
    • 0019935881 scopus 로고
    • Rapid changes in the concentration of phosphoenolpyruvate carboxykinase mRNA in rat liver and kidney. Effects of insulin and cyclic AMP
    • Cimbala, A.N.; Lamers, W.H.; Nelson, J.E.; Monahan, J.E.; Yoo-Warren, H.; Hanson, R.W. Rapid changes in the concentration of phosphoenolpyruvate carboxykinase mRNA in rat liver and kidney. Effects of insulin and cyclic AMP. J. Biol. Chem., 1982, 257 (13), 7629-7636.
    • (1982) J. Biol. Chem. , vol.257 , Issue.13 , pp. 7629-7636
    • Cimbala, A.N.1    Lamers, W.H.2    Nelson, J.E.3    Monahan, J.E.4    Yoo-Warren, H.5    Hanson, R.W.6
  • 85
    • 0242687126 scopus 로고    scopus 로고
    • Parasite Mitochondria as Drug Target: Diversity and Dynamic Changes during the Life Cycle
    • Kita, K.; Nihei, C.; Tomitsuka, E. Parasite Mitochondria as Drug Target: Diversity and Dynamic Changes During the Life Cycle. Curr. Med. Chem., 2003, 10 (23), 2535-2548.
    • (2003) Curr. Med. Chem. , vol.10 , Issue.23 , pp. 2535-2548
    • Kita, K.1    Nihei, C.2    Tomitsuka, E.3
  • 86
    • 0037163021 scopus 로고    scopus 로고
    • The key role of anaplerosis and cataplerosis for citric acid cycle function
    • Owen, O.E.; Kalhan, S.C.; and Hanson, R.W. The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem., 2002, 277 (34), 30409-30412.
    • (2002) J. Biol. Chem. , vol.277 , Issue.34 , pp. 30409-30412
    • Owen, O.E.1    Kalhan, S.C.2    Hanson, R.W.3
  • 87
    • 0034826624 scopus 로고    scopus 로고
    • Mechanism of increased renal gene expression during metabolic acidosis
    • Curthoys, N.P.; Gstraunthaler, G. Mechanism of increased renal gene expression during metabolic acidosis. Am. J. Physiol. Renal Physiol., 2001, 281 (3), F381-F390.
    • (2001) Am. J. Physiol. Renal Physiol. , vol.281 , Issue.3
    • Curthoys, N.P.1    Gstraunthaler, G.2
  • 88
    • 0035088022 scopus 로고    scopus 로고
    • Rat small intestine is an insulin-sensitive gluconeogenic organ
    • Croset, M.; Rajas, F.; Zitoun, C.; Hurot, J.M.; Montano, S.; Mithieux, G. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes, 2001, 50 (4), 740-746.
    • (2001) Diabetes , vol.50 , Issue.4 , pp. 740-746
    • Croset, M.1    Rajas, F.2    Zitoun, C.3    Hurot, J.M.4    Montano, S.5    Mithieux, G.6
  • 89
    • 30344450829 scopus 로고    scopus 로고
    • Overcoming Diabetes-Induced Hyperglycemia through Inhibition of Hepatic Phosphoenolpyruvate Carboxykinase (GTP) with RNAi
    • Gómez-Valadés, A.G.; Vidal-Alabró, A.; Molas, M.; Boada, J.; Bermúdez, J.; Bartrons, R.; Perales, J.C. Overcoming Diabetes-Induced Hyperglycemia through Inhibition of Hepatic Phosphoenolpyruvate Carboxykinase (GTP) with RNAi. Mol. Ther., 2006, 13 (2), 401-410.
    • (2006) Mol. Ther. , vol.13 , Issue.2 , pp. 401-410
    • Gómez-Valadés, A.G.1    Vidal-Alabró, A.2    Molas, M.3    Boada, J.4    Bermúdez, J.5    Bartrons, R.6    Perales, J.C.7
  • 90
    • 0030998776 scopus 로고    scopus 로고
    • Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression
    • Hanson, R.W.; Reshef, L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem., 1997, 66 (1), 581-611.
    • (1997) Annu. Rev. Biochem. , vol.66 , Issue.1 , pp. 581-611
    • Hanson, R.W.1    Reshef, L.2
  • 91
    • 0141786821 scopus 로고    scopus 로고
    • Modified 3-Alkyl-1, 8-dibenzylxanthines as GTP-Competitive inhibitors of phosphoenolpyruvate carboxykinase
    • Foley, L.H.; Wang, P.; Dunten, P.; Ramsey, G.; Gubler, M.-L.; Wertheimer, S.J. Modified 3-Alkyl-1, 8-dibenzylxanthines as GTP-Competitive inhibitors of phosphoenolpyruvate carboxykinase. Bioorg. Med. Chem. Lett., 2003, 13 (20), 3607-3610.
    • (2003) Bioorg. Med. Chem. Lett. , vol.13 , Issue.20 , pp. 3607-3610
    • Foley, L.H.1    Wang, P.2    Dunten, P.3    Ramsey, G.4    Gubler, M.-L.5    Wertheimer, S.J.6
  • 92
    • 0141545054 scopus 로고    scopus 로고
    • X-ray Structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1, 8-Dibenzylxanthines
    • Foley, L.H.; Wang, P.; Dunten, P.; Ramsey, G.; Gubler, M.-L.; Wertheimer, S.J. X-ray Structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1, 8-Dibenzylxanthines. Bioorg. Med. Chem. Lett., 2003, 13 (21), 3871-3874.
    • (2003) Bioorg. Med. Chem. Lett. , vol.13 , Issue.21 , pp. 3871-3874
    • Foley, L.H.1    Wang, P.2    Dunten, P.3    Ramsey, G.4    Gubler, M.-L.5    Wertheimer, S.J.6
  • 94
    • 0024839184 scopus 로고
    • Banting lecture 1989. Structure and function of insulin receptors
    • Rosen, O.M. Banting lecture 1989. Structure and function of insulin receptors. Diabetes, 1989, 38 (12), 1508-1511.
    • (1989) Diabetes , vol.38 , Issue.12 , pp. 1508-1511
    • Rosen, O.M.1
  • 96
    • 0025945012 scopus 로고
    • Insulin resistance-mechanisms, syndromes, and implications
    • Moller, D.E.; Flier, J.S. Insulin resistance-mechanisms, syndromes, and implications. N. Engl. J. Med., 1991, 325 (13), 938-948.
    • (1991) N. Engl. J. Med. , vol.325 , Issue.13 , pp. 938-948
    • Moller, D.E.1    Flier, J.S.2
  • 97
    • 0027953703 scopus 로고
    • Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes
    • Kahn, C.R. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes, 1994, 43 (8), 1066-1084.
    • (1994) Diabetes , vol.43 , Issue.8 , pp. 1066-1084
    • Kahn, C.R.1
  • 98
    • 33845432866 scopus 로고    scopus 로고
    • Regulating insulin signaling and beta-cell function through IRS proteins
    • White, M.F. Regulating insulin signaling and beta-cell function through IRS proteins. Can. J. Physiol. Pharmacol., 2006, 84 (7), 725-737.
    • (2006) Can. J. Physiol. Pharmacol. , vol.84 , Issue.7 , pp. 725-737
    • White, M.F.1
  • 101
    • 33947596679 scopus 로고    scopus 로고
    • The GLUT4 glucose transporter
    • Huang, S.; Czech, M.P. The GLUT4 glucose transporter. Cell Metab., 2007, 5 (4), 237-252.
    • (2007) Cell Metab. , vol.5 , Issue.4 , pp. 237-252
    • Huang, S.1    Czech, M.P.2
  • 103
    • 0036433407 scopus 로고    scopus 로고
    • Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus
    • Laborde, E.; Manchem, V.P. Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus. Curr. Med. Chem., 2002, 9 (24), 2231.
    • (2002) Curr. Med. Chem. , vol.9 , Issue.24 , pp. 2231
    • Laborde, E.1    Manchem, V.P.2
  • 106
    • 4444289382 scopus 로고    scopus 로고
    • Negative glucocorticoid receptor response elements and their role in glucocorticoid action
    • Dostert, A.; Heinzel, T. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr. Pharm. Des., 2004, 10 (23), 2807-2816.
    • (2004) Curr. Pharm. Des. , vol.10 , Issue.23 , pp. 2807-2816
    • Dostert, A.1    Heinzel, T.2
  • 107
    • 0021356212 scopus 로고
    • Hormonal regulation of hepatic gluconeogenesis
    • Kraus-Friedmann, N. Hormonal regulation of hepatic gluconeogenesis. Physiol. Rev., 1984, 64 (1), 170-259.
    • (1984) Physiol. Rev. , vol.64 , Issue.1 , pp. 170-259
    • Kraus-Friedmann, N.1
  • 108
    • 0033617150 scopus 로고    scopus 로고
    • Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation
    • Smas, CM.; Chen, L.; Zhao, L.; Latasa, M.J.; Sul, H.S. Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation. J. Biol. Chem., 1999, 274 (18), 12632-12641.
    • (1999) J. Biol. Chem. , vol.274 , Issue.18 , pp. 12632-12641
    • Smas, C.M.1    Chen, L.2    Zhao, L.3    Latasa, M.J.4    Sul, H.S.5
  • 110
    • 0035656177 scopus 로고    scopus 로고
    • Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases
    • Sandeep, T.C.; Walker, B.R. Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases. Trends in Endocrinol. Metab., 2001, 12 (10), 446-453.
    • (2001) Trends in Endocrinol. Metab. , vol.12 , Issue.10 , pp. 446-453
    • Sandeep, T.C.1    Walker, B.R.2
  • 111
    • 0028034209 scopus 로고
    • Cloning and tissue distribution of the human 11 ß-hydroxysteroid dehydrogenase type 2 enzyme
    • Albiston, A.L.; Obeyesekere, V.R.; Smith, R.E.; Krozowski, Z.S. Cloning and tissue distribution of the human 11 ß-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrin., 1994, 105 (1), 11-17.
    • (1994) Mol. Cell. Endocrin. , vol.105 , Issue.1 , pp. 11-17
    • Albiston, A.L.1    Obeyesekere, V.R.2    Smith, R.E.3    Krozowski, Z.S.4
  • 112
    • 61849114268 scopus 로고    scopus 로고
    • Glucocorticoids, 11beta-hydroxyster oid dehydrogenase: Mother, fetus, or both?
    • Challis, J.R.; Connor, K. Glucocorticoids, 11beta-hydroxyster oid dehydrogenase: mother, fetus, or both? Endocrinology, 2009, 150 (3), 1073-1074.
    • (2009) Endocrinology , vol.150 , Issue.3 , pp. 1073-1074
    • Challis, J.R.1    Connor, K.2
  • 114
    • 0031046241 scopus 로고    scopus 로고
    • 11 beta-Hydro xyster o id dehydrogenase and the syndrome of apparent mineralocorticoid excess
    • White, P. C.; Mune, T.; Agarwal, A.K. 11 beta-Hydro xyster o id dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev, 1997, 18 (1), 135-136.
    • (1997) Endocr. Rev , vol.18 , Issue.1 , pp. 135-136
    • White, P.C.1    Mune, T.2    Agarwal, A.K.3
  • 116
    • 12144291638 scopus 로고    scopus 로고
    • Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice
    • Morton, N.M.; Paterson, J.M.; Masuzaki, H.; Holmes, M.C.; Staels, B.; Fievet, C; Walker, B.R.; Flier, J.S.; Mullins, J.J.; Seckl, J.R. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes, 2004, 53 (4), 931-938.
    • (2004) Diabetes , vol.53 , Issue.4 , pp. 931-938
    • Morton, N.M.1    Paterson, J.M.2    Masuzaki, H.3    Holmes, M.C.4    Staels, B.5    Fievet, C.6    Walker, B.R.7    Flier, J.S.8    Mullins, J.J.9    Seckl, J.R.10
  • 118
    • 59149094004 scopus 로고    scopus 로고
    • Inhibitors of 11beta-HSD1: A potential treatment for the metabolic syndrome
    • St Jean, D.J.; Wang, M.; Fotsch, C. Inhibitors of 11beta-HSD1: a potential treatment for the metabolic syndrome. Curr. Top. Med. Chem., 2008, 8 (17), 1508-1523.
    • (2008) Curr. Top. Med. Chem. , vol.8 , Issue.17 , pp. 1508-1523
    • St Jean, D.J.1    Wang, M.2    Fotsch, C.3
  • 119
    • 34447105433 scopus 로고    scopus 로고
    • Inhibition of 11beta-hydroxy steroid dehydrogenase type 1 as a promising therapeutic target
    • Wamil, M.; Seckl, J.R. Inhibition of 11beta-hydroxy steroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov. Today, 2007, 12 (13-14), 504-520.
    • (2007) Drug Discov. Today , vol.12 , Issue.13-14 , pp. 504-520
    • Wamil, M.1    Seckl, J.R.2
  • 120
    • 46749112663 scopus 로고    scopus 로고
    • Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes
    • Hale, C; Wang, M. Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes. Mini. Rev. Med. Chem., 2008, 8 (7), 702-710.
    • (2008) Mini. Rev. Med. Chem. , vol.8 , Issue.7 , pp. 702-710
    • Hale, C.1    Wang, M.2
  • 121
    • 77950664531 scopus 로고    scopus 로고
    • 11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
    • Ge, R.; Huang, Y; Liang, G.; Li, X. 11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development. Curr. Med. Chem., 2010, 17 (5), 412-422.
    • (2010) Curr. Med. Chem. , vol.17 , Issue.5 , pp. 412-422
    • Ge, R.1    Huang, Y.2    Liang, G.3    Li, X.4
  • 123
    • 0036432995 scopus 로고    scopus 로고
    • Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
    • Alberts, P.; Engblom, L.; Edling, N; Forsgren, M.; Klingstrom, G.; Larsson, C; Ronquist-Nii, Y; Ohman, B.; Abrahmsen, L. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia, 2002, 45 (11), 1528-1532.
    • (2002) Diabetologia , vol.45 , Issue.11 , pp. 1528-1532
    • Alberts, P.1    Engblom, L.2    Edling, N.3    Forsgren, M.4    Klingstrom, G.5    Larsson, C.6    Ronquist-Nii, Y.7    Ohman, B.8    Abrahmsen, L.9
  • 125
    • 21144456678 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of sulfonamidooxazoles and ß-keto sulfones: Selective inhibitors of 11 ß-hydroxysteroid dehydrogenase type i
    • Xiang, J.; Ipek, M.; Suri, V; Massefski, W.; Pan, N; Ge, Y; Tam, M.; Xing, Y.; Tobin, J.F.; Xu, X. Synthesis and biological evaluation of sulfonamidooxazoles and ß-keto sulfones: selective inhibitors of 11 ß-hydroxysteroid dehydrogenase type I. Bioorg. Med. Chem. Lett, 2005, 15 (11), 2865-2869.
    • (2005) Bioorg. Med. Chem. Lett , vol.15 , Issue.11 , pp. 2865-2869
    • Xiang, J.1    Ipek, M.2    Suri, V.3    Massefski, W.4    Pan, N.5    Ge, Y.6    Tam, M.7    Xing, Y.8    Tobin, J.F.9    Xu, X.10
  • 127
    • 34247132757 scopus 로고    scopus 로고
    • Assay optimization and kinetic profile of the human and the rabbit isoforms of 11beta-HSD1
    • Castro, A.; Zhu, J.X.; Alton, G.R.; Rejto, P.; Ermolieff, J. Assay optimization and kinetic profile of the human and the rabbit isoforms of 11beta-HSD1. Biochem. Biophys. Res. Commun., 2007, 357 (2), 561-566.
    • (2007) Biochem. Biophys. Res. Commun. , vol.357 , Issue.2 , pp. 561-566
    • Castro, A.1    Zhu, J.X.2    Alton, G.R.3    Rejto, P.4    Ermolieff, J.5
  • 129
    • 50249091534 scopus 로고    scopus 로고
    • Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11 ß-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 Diabetes
    • Fotsch, C; Wang, M. Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11 ß-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 Diabetes. J. Med. Chem., 2008, 51 (16), 4851-4857.
    • (2008) J. Med. Chem. , vol.51 , Issue.16 , pp. 4851-4857
    • Fotsch, C.1    Wang, M.2
  • 131
    • 52949108814 scopus 로고    scopus 로고
    • Distinctive molecular inhibition mechanisms for selective inhibitors of human 11 ß-hydroxysteroid dehydrogenase type 1
    • Tu, H.; Powers, J.P; Liu, J.; Ursu, S.; Sudom, A.; Yan, X.; Xu, H.; Meininger, D.; DeGraffenreid, M.; He, X. Distinctive molecular inhibition mechanisms for selective inhibitors of human 11 ß-hydroxysteroid dehydrogenase type 1. Bioorg. Med. Chem., 2008, 16 (19), 8922-8931.
    • (2008) Bioorg. Med. Chem. , vol.16 , Issue.19 , pp. 8922-8931
    • Tu, H.1    Powers, J.P.2    Liu, J.3    Ursu, S.4    Sudom, A.5    Yan, X.6    Xu, H.7    Meininger, D.8    Degraffenreid, M.9    He, X.10
  • 132
    • 47749122576 scopus 로고    scopus 로고
    • Piperazine Sulfonamides as Potent, Selective, and Orally Available 11 ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitors with Efficacy in the Rat Cortisone-Induced Hyp er insulin emia Model
    • Xiang, J.; Wan, Z.-K.; Li, H.-Q.; Ipek, M.; Binnun, E.; Nunez, J.; Chen, L.; McKew, J.C.; Mansour, T.S.; Xu, X.; Suri, V.; Tam, M.; Xing, Y; Li, X.; Hahm, S.; Tobin, J.; Saiah, E. Piperazine Sulfonamides as Potent, Selective, and Orally Available 11 ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitors with Efficacy in the Rat Cortisone-Induced Hyp er insulin emia Model. J. Med. Chem., 2008, 51 (14), 4068-4071.
    • (2008) J. Med. Chem. , vol.51 , Issue.14 , pp. 4068-4071
    • Xiang, J.1    Wan, Z.-K.2    Li, H.-Q.3    Ipek, M.4    Binnun, E.5    Nunez, J.6    Chen, L.7    McKew, J.C.8    Mansour, T.S.9    Xu, X.10    Suri, V.11    Tam, M.12    Xing, Y.13    Li, X.14    Hahm, S.15    Tobin, J.16    Saiah, E.17
  • 134
    • 60849135109 scopus 로고    scopus 로고
    • Structure-based virtual screening for identification of novel
    • Yang, H. Y; Shen, Y; Chen, J.H.; Jiang, Q. F.; Leng, Y; Shen, J.H. Structure-based virtual screening for identification of novel 11ß-HSD1 inhibitors. Eur. J. Med. Chem., 2009, 44 (3), 1167-1171.
    • (2009) Eur. J. Med. Chem. , vol.44 , Issue.3 , pp. 1167-1171
    • Yang, H.Y.1    Shen, Y.2    Chen, J.H.3    Jiang, Q.F.4    Leng, Y.5    Shen, J.H.6
  • 135
    • 67650178262 scopus 로고    scopus 로고
    • 4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11[beta]-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice
    • Zhang, X.; Zhou, Z.; Yang, H.; Chen, J.; Feng, Y; Du, L.; Leng, Y; Shen, J. 4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11[beta]-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice. Bioorg. Med. Chem. Lett, 2009, 19 (15), 4455-4458.
    • (2009) Bioorg. Med. Chem. Lett , vol.19 , Issue.15 , pp. 4455-4458
    • Zhang, X.1    Zhou, Z.2    Yang, H.3    Chen, J.4    Feng, Y.5    Du, L.6    Leng, Y.7    Shen, J.8
  • 136
    • 33644916083 scopus 로고    scopus 로고
    • Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1
    • Su, X.; Vicker, N; Ganeshapillai, D.; Smith, A.; Purohit, A.; Reed, M.J.; Potter, B.V. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Mol. Cell. Endocrinol, 2006, 248 (1-2), 214-217.
    • (2006) Mol. Cell. Endocrinol , vol.248 , Issue.1-2 , pp. 214-217
    • Su, X.1    Vicker, N.2    Ganeshapillai, D.3    Smith, A.4    Purohit, A.5    Reed, M.J.6    Potter, B.V.7
  • 139
    • 42049102780 scopus 로고    scopus 로고
    • The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors
    • Saiah, E. The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors. Curr. Med. Chem., 2008, 15 (7), 642-649.
    • (2008) Curr. Med. Chem. , vol.15 , Issue.7 , pp. 642-649
    • Saiah, E.1
  • 143
    • 0032897899 scopus 로고    scopus 로고
    • Protein Tyrosine Phosphatases; Their Role in Insulin Action and Potential as Drug Targets
    • Evans, J.L.; Jallal, B. Protein Tyrosine Phosphatases; Their Role in Insulin Action and Potential as Drug Targets. Exp. Opin. Invest. Drugs 1999, 8 (2), 139-160.
    • (1999) Exp. Opin. Invest. Drugs , vol.8 , Issue.2 , pp. 139-160
    • Evans, J.L.1    Jallal, B.2
  • 144
    • 0030953448 scopus 로고    scopus 로고
    • Protein tyrosine phosphatases in signal transduction
    • Neel, B.G.; Tonks, N.K. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol, 1997, 9 (2), 193-204.
    • (1997) Curr. Opin. Cell Biol , vol.9 , Issue.2 , pp. 193-204
    • Neel, B.G.1    Tonks, N.K.2
  • 145
    • 34347260715 scopus 로고    scopus 로고
    • Recent Development of Small Molecular Specic Inhibitor of ProteinTyrosine Phosphatase 1B
    • Lee, S.; Wang, Q. Recent Development of Small Molecular Specic Inhibitor of ProteinTyrosine Phosphatase 1B. Med. Res. Rev., 2007, 27 (4), 553-573.
    • (2007) Med. Res. Rev. , vol.27 , Issue.4 , pp. 553-573
    • Lee, S.1    Wang, Q.2
  • 146
    • 0036090978 scopus 로고    scopus 로고
    • Protein Tyrosine Phosphatase 1B: A New Target for the Treatment of Obesity and Associated Co-Morbidities
    • Ukkola, O.; Santaniemi, M. Protein Tyrosine Phosphatase 1B: A New Target for the Treatment of Obesity and Associated Co-Morbidities. J. Intern. Med, 2002, 252 (6), 467-475.
    • (2002) J. Intern. Med , vol.252 , Issue.6 , pp. 467-475
    • Ukkola, O.1    Santaniemi, M.2
  • 147
    • 0026500524 scopus 로고
    • Protein-Tyrosine Phosphatases and the Regulation of Insulin Action
    • Goldstein, B.J. Protein-Tyrosine Phosphatases and the Regulation of Insulin Action. J. Cell. Biochem., 1992, 48 (1), 33-42.
    • (1992) J. Cell. Biochem. , vol.48 , Issue.1 , pp. 33-42
    • Goldstein, B.J.1
  • 150
    • 0036183603 scopus 로고    scopus 로고
    • Coordinated action of protein tyrosine phosphatases in insulin signal transduction
    • Cheng, A.; Dube, N; Gu, F.; Trembley, M.L. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur. J. Biochem., 2002, 269 (4), 1050-1059.
    • (2002) Eur. J. Biochem. , vol.269 , Issue.4 , pp. 1050-1059
    • Cheng, A.1    Dube, N.2    Gu, F.3    Trembley, M.L.4
  • 152
    • 0033600797 scopus 로고    scopus 로고
    • The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling
    • Tiganis, T.; Kemp, B.E.; Tonks, N.K. The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J. Biol. Chem., 1999, 274 (39), 27768-27775.
    • (1999) J. Biol. Chem. , vol.274 , Issue.39 , pp. 27768-27775
    • Tiganis, T.1    Kemp, B.E.2    Tonks, N.K.3
  • 153
    • 0038661384 scopus 로고    scopus 로고
    • Inhibitors of protein tyrosine phosphatase 1B (PTP1B)
    • Taylor, S.D. Inhibitors of protein tyrosine phosphatase 1B (PTP1B). Curr. Top. Med. Chem., 2003, 3 (7), 759-782.
    • (2003) Curr. Top. Med. Chem. , vol.3 , Issue.7 , pp. 759-782
    • Taylor, S.D.1
  • 154
    • 3843121119 scopus 로고    scopus 로고
    • Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs
    • Hooft van Huijsduijnen, R.H.; Sauer, W.H.B.; Bombrun, A.; Swinnen, D. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J. Med. Chem., 2004, 47 (17), 4142-4146.
    • (2004) J. Med. Chem. , vol.47 , Issue.17 , pp. 4142-4146
    • Hooft Van Huijsduijnen, R.H.1    Sauer, W.H.B.2    Bombrun, A.3    Swinnen, D.4
  • 155
    • 21244444303 scopus 로고    scopus 로고
    • Inhibitors of protein tyrosine phosphatases: Next-generation drugs
    • Bialy, L.; Waldmann, H. Inhibitors of protein tyrosine phosphatases: Next-generation drugs? Angew. Chem. Int. Ed, 2005, 44 (25), 3814-3839.
    • (2005) Angew. Chem. Int. Ed , vol.44 , Issue.25 , pp. 3814-3839
    • Bialy, L.1    Waldmann, H.2
  • 156
    • 77949845981 scopus 로고    scopus 로고
    • Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer
    • Combs, A. P. Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer. J. Med. Chem., 2010, 53 (6), 2333-2344.
    • (2010) J. Med. Chem. , vol.53 , Issue.6 , pp. 2333-2344
    • Combs, A.P.1
  • 157
    • 0041809012 scopus 로고    scopus 로고
    • Protein Tyrosine Phosphatase 1B Inhibition: Opportunities and Challenges
    • Liu, G. Protein Tyrosine Phosphatase 1B Inhibition: Opportunities and Challenges. Curr. Med. Chem., 2003, 10 (15), 1407-1421.
    • (2003) Curr. Med. Chem. , vol.10 , Issue.15 , pp. 1407-1421
    • Liu, G.1
  • 158
    • 0028077830 scopus 로고
    • Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp
    • Burke, T.R., Jr.; Kole, H.K.; Roller, P.P. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp. Biochem. Biophys. Res. Commun., 1994, 204 (1), 129-134.
    • (1994) Biochem. Biophys. Res. Commun. , vol.204 , Issue.1 , pp. 129-134
    • Burke, Jr.T.R.1    Kole, H.K.2    Roller, P.P.3
  • 159
  • 161
    • 1842424803 scopus 로고    scopus 로고
    • Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells
    • Romsicki, Y; Reece, M.; Gauthier, J.-Y; Asante-Appiah, E.; Kennedy, B.P. Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells. J. Biol. Chem., 2004, 279 (13), 12868-12875.
    • (2004) J. Biol. Chem. , vol.279 , Issue.13 , pp. 12868-12875
    • Romsicki, Y.1    Reece, M.2    Gauthier, J.-Y.3    Asante-Appiah, E.4    Kennedy, B.P.5
  • 162
    • 47349122949 scopus 로고    scopus 로고
    • A re-examination of the difluoromethylenesulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition
    • Hussain, M.; Ahmed, V; Hill, B.; Ahmed, Z.; Taylor, S.D. A re-examination of the difluoromethylenesulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition. Bioorg. Med. Chem., 2008, 16 (14), 6764-6777.
    • (2008) Bioorg. Med. Chem. , vol.16 , Issue.14 , pp. 6764-6777
    • Hussain, M.1    Ahmed, V.2    Hill, B.3    Ahmed, Z.4    Taylor, S.D.5
  • 163
    • 0037377337 scopus 로고    scopus 로고
    • Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases
    • Huang, P.; Ramphal, J.; Wei, J.; Liang, C; Jallal, B.; McMahon, G.; Tang, C. Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases. Bioorg. Med. Chem., 2003, 11, 1835-1849.
    • (2003) Bioorg. Med. Chem. , vol.11 , pp. 1835-1849
    • Huang, P.1    Ramphal, J.2    Wei, J.3    Liang, C.4    Jallal, B.5    McMahon, G.6    Tang, C.7
  • 177
    • 0035847677 scopus 로고    scopus 로고
    • Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases
    • Wipf, P.; Aslan, D.C.; Southwick, E.C.; Lazo, J.S. Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases. Bioorg. Med. Chem. Lett., 2001, 11 (3), 313-317.
    • (2001) Bioorg. Med. Chem. Lett. , vol.11 , Issue.3 , pp. 313-317
    • Wipf, P.1    Aslan, D.C.2    Southwick, E.C.3    Lazo, J.S.4
  • 179
    • 70349386312 scopus 로고    scopus 로고
    • Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
    • Matteucci, E.; Giampietro, O. Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme. Curr. Med. Chem., 2009, 16 (23), 2943-2951.
    • (2009) Curr. Med. Chem. , vol.16 , Issue.23 , pp. 2943-2951
    • Matteucci, E.1    Giampietro, O.2
  • 180
    • 61349143225 scopus 로고    scopus 로고
    • Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes
    • Havale, S.H.; Pal, M. Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. Bioorg. Med. Chem., 2009, 17 (5), 1783-1802.
    • (2009) Bioorg. Med. Chem. , vol.17 , Issue.5 , pp. 1783-1802
    • Havale, S.H.1    Pal, M.2
  • 181
    • 0027215348 scopus 로고
    • Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum
    • Mentlein, R.; Gallwitz, B.; Schmidt, W.E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem., 1993, 214 (3), 829-835.
    • (1993) Eur. J. Biochem. , vol.214 , Issue.3 , pp. 829-835
    • Mentlein, R.1    Gallwitz, B.2    Schmidt, W.E.3
  • 182
    • 3843072211 scopus 로고    scopus 로고
    • Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
    • Weber, A.E. Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes. J. Med. Chem., 2004, 47 (17), 4135-4141.
    • (2004) J. Med. Chem. , vol.47 , Issue.17 , pp. 4135-4141
    • Weber, A.E.1
  • 183
    • 2342513750 scopus 로고    scopus 로고
    • Combined genetic disruption of dual incretin receptor signaling pathways reveals novel glucose lowering properties of DPP-IV inhibitors in mice
    • Hansotia, T.; Baggio, L.; Yamada, Y.; Tsukiyama, K.; Preitner, F.; Thorens, B.; Seino, Y.; Drucker, D. Combined genetic disruption of dual incretin receptor signaling pathways reveals novel glucose lowering properties of DPP-IV inhibitors in mice. Diabetes, 2003, 52 (S1), A77-A78.
    • (2003) Diabetes , vol.52 , Issue.S1
    • Hansotia, T.1    Baggio, L.2    Yamada, Y.3    Tsukiyama, K.4    Preitner, F.5    Thorens, B.6    Seino, Y.7    Drucker, D.8
  • 187
    • 0037777695 scopus 로고    scopus 로고
    • 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties
    • Villhauer, E.B.; Brinkman, J.A.; Naderi, G.B.; Burkey, B.F.; Dunning, B.E.; Prasad, K.; Mangold, B.L.; Russell, M.E.; Hughes, T.E. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J. Med. Chem., 2003, 46 (13), 2774-2789.
    • (2003) J. Med. Chem. , vol.46 , Issue.13 , pp. 2774-2789
    • Villhauer, E.B.1    Brinkman, J.A.2    Naderi, G.B.3    Burkey, B.F.4    Dunning, B.E.5    Prasad, K.6    Mangold, B.L.7    Russell, M.E.8    Hughes, T.E.9
  • 190
    • 10744220490 scopus 로고    scopus 로고
    • Diastereoselective synthesis and configuration-dep end ent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors
    • Ashton, W.T.; Dong, H.; Sisco, RM.; Doss, G.A.; Leiting, B.; Patel, R.A.; Wu, J.K.; Marsilio, F.; Thornberry, N.A.; Weber, A.E. Diastereoselective synthesis and configuration-dep end ent activity of (3-substituted-cycloalkyl) glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors. Bioorg. Med. Chem. Lett., 2004, 14 (4), 859-863.
    • (2004) Bioorg. Med. Chem. Lett. , vol.14 , Issue.4 , pp. 859-863
    • Ashton, W.T.1    Dong, H.2    Sisco, R.M.3    Doss, G.A.4    Leiting, B.5    Patel, R.A.6    Wu, J.K.7    Marsilio, F.8    Thornberry, N.A.9    Weber, A.E.10
  • 191
    • 58449107784 scopus 로고    scopus 로고
    • D-420720, A novel orally active sulfonamide compound dipeptidyl peptidase IV inhibitor: Structure and activity relationship of arylsulfonamide to dipeptidyl peptidase IV inhibition
    • Tsai, H.J.; Chou, S.-Y.; Chuang, S.-H.; Chen, C.-C; Hsu, F.-L. D-420720, A novel orally active sulfonamide compound dipeptidyl peptidase IV inhibitor: structure and activity relationship of arylsulfonamide to dipeptidyl peptidase IV inhibition. Drug Dev. Res., 2008, 69 (8), 514-519.
    • (2008) Drug Dev. Res. , vol.69 , Issue.8 , pp. 514-519
    • Tsai, H.J.1    Chou, S.-Y.2    Chuang, S.-H.3    Chen, C.-C.4    Hsu, F.-L.5
  • 195
    • 53349165532 scopus 로고    scopus 로고
    • (3R)-3-Amino-4-(2, 4, 5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy) benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    • Nitta, A.; Fujii, H.; Sakami, S.; Nishimura, Y.; Ohyama, T; Satoh, M.; Nakaki, J.; Satoh, S.; Inada, C; Kozono, H.; Kumagai, H.; Shimamura, M.; Fukazawa, T.; Kawai, H. (3R)-3-Amino-4-(2, 4, 5-trifluorophenyl)-N-{4-[6-(2- methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg. Med. Chem. Lett, 2008, 18 (20), 5435-5438.
    • (2008) Bioorg. Med. Chem. Lett , vol.18 , Issue.20 , pp. 5435-5438
    • Nitta, A.1    Fujii, H.2    Sakami, S.3    Nishimura, Y.4    Ohyama, T.5    Satoh, M.6    Nakaki, J.7    Satoh, S.8    Inada, C.9    Kozono, H.10    Kumagai, H.11    Shimamura, M.12    Fukazawa, T.13    Kawai, H.14
  • 197
  • 198
    • 79952364204 scopus 로고    scopus 로고
    • Discovery of potent dipeptidyl peptidase IV inhibitors derived from [beta]-aminoamides bearing substituted [1, 2, 3]-triazolopiperidines for the treatment of type 2 diabetes
    • Shan, Z.; Peng, M.; Fan, H.; Lu, Q.; Lu, P.; Zhao, C; Chen, Y Discovery of potent dipeptidyl peptidase IV inhibitors derived from [beta]-aminoamides bearing substituted [1, 2, 3]-triazolopiperidines for the treatment of type 2 diabetes. Bioorg. Med. Chem. Lett, 2011, 21 (6), 1731-1735.
    • (2011) Bioorg. Med. Chem. Lett , vol.21 , Issue.6 , pp. 1731-1735
    • Shan, Z.1    Peng, M.2    Fan, H.3    Lu, Q.4    Lu, P.5    Zhao, C.6    Chen, Y.7
  • 202
    • 0014014125 scopus 로고
    • Sorbitol pathway: Presence in nerve and cord with substrate accumulation in diabetes
    • Gabbay, K.H.; Merola, L.O.; Field, R.A. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science, 1966, 151 (3707), 209-210.
    • (1966) Science , vol.151 , Issue.3707 , pp. 209-210
    • Gabbay, K.H.1    Merola, L.O.2    Field, R.A.3
  • 203
    • 78649860273 scopus 로고
    • Long-term complications of diabetes mellitus
    • Nathan, DM. Long-term complications of diabetes mellitus. N. Engl. J. Med., 1988, 318 (20), 1315-1321.
    • (1988) N. Engl. J. Med. , vol.318 , Issue.20 , pp. 1315-1321
    • Nathan, D.M.1
  • 204
    • 0000841548 scopus 로고
    • Formation of polyols by the lens of the lens of the rat with sugar cataract
    • van Heyningen, R. Formation of polyols by the lens of the lens of the rat with sugar cataract. Nature (Lond.), 1959, 184 (S4), 194-195.
    • (1959) Nature (Lond.) , vol.184 , Issue.S4 , pp. 194-195
    • Van Heyningen, R.1
  • 205
    • 0031752685 scopus 로고    scopus 로고
    • Global Burden of Diabetes, 1995-2025. Prevalence, Numeric Estimates, and Projections
    • King, H.; Aubert, R.E.; Herman, W.H. Global Burden of Diabetes, 1995-2025. Prevalence, Numeric Estimates, and Projections. Diabetes Care., 1998, 21 (9), 1414-1431.
    • (1998) Diabetes Care. , vol.21 , Issue.9 , pp. 1414-1431
    • King, H.1    Aubert, R.E.2    Herman, W.H.3
  • 206
    • 0027730267 scopus 로고
    • Lessons Learned from Use of Cyclosporine for Insulin-Dependent Diabetes Mellitus
    • Mahon, J.L.; Dupre, J.; Stiller, C.R. Lessons Learned from Use of Cyclosporine for Insulin-Dependent Diabetes Mellitus. Ann. N.Y. Acad. Sci., 1993, 696 (1), 351-363.
    • (1993) Ann. N.Y. Acad. Sci. , vol.696 , Issue.1 , pp. 351-363
    • Mahon, J.L.1    Dupre, J.2    Stiller, C.R.3
  • 207
    • 0035856980 scopus 로고    scopus 로고
    • Biochemistry and Molecular Cell Biology of Diabetic Complications
    • Brownlee, M. Biochemistry and Molecular Cell Biology of Diabetic Complications. Nature, 2001, 414 (6865), 813-820.
    • (2001) Nature , vol.414 , Issue.6865 , pp. 813-820
    • Brownlee, M.1
  • 208
    • 20444380690 scopus 로고    scopus 로고
    • Cellular Mechanisms and Treatment of Diabetes Vascular Complications Converge on Reactive Oxygen Species
    • Whiteside, C.I. Cellular Mechanisms and Treatment of Diabetes Vascular Complications Converge on Reactive Oxygen Species. Curr. Hypertens. Rep., 2005, 7 (2), 148-154.
    • (2005) Curr. Hypertens. Rep. , vol.7 , Issue.2 , pp. 148-154
    • Whiteside, C.I.1
  • 209
    • 0027934146 scopus 로고
    • Aldose Reductase Inhibitors and Their Potential for the Treatment of Diabetic Complications
    • Tomlinson, D.R.; Stevens, E.J.; Diemel, L.T. Aldose Reductase Inhibitors and Their Potential for the Treatment of Diabetic Complications. Trends Pharmacol. Sci., 1994, 15 (8), 293-297.
    • (1994) Trends Pharmacol. Sci. , vol.15 , Issue.8 , pp. 293-297
    • Tomlinson, D.R.1    Stevens, E.J.2    Diemel, L.T.3
  • 210
    • 0023899991 scopus 로고
    • The Role of Aldose Reductase in the Development of Diabetic Complications
    • Kador, P.F. The Role of Aldose Reductase in the Development of Diabetic Complications. Med. Res. Rev., 1988, 8 (3), 325-352.
    • (1988) Med. Res. Rev. , vol.8 , Issue.3 , pp. 325-352
    • Kador, P.F.1
  • 211
    • 0023913225 scopus 로고
    • The involvement of aldose reductase in diabetic complications
    • Kinoshita, J.H.; Nishimura, C. The involvement of aldose reductase in diabetic complications. Diabetes Metab. Rev., 1988, 4 (4), 323-337.
    • (1988) Diabetes Metab. Rev. , vol.4 , Issue.4 , pp. 323-337
    • Kinoshita, J.H.1    Nishimura, C.2
  • 212
    • 0021828899 scopus 로고
    • Aldose reductase inhibitors: A potential new class of agents for the pharmacological control of certain diabetic complications
    • Kador, P.F.; Kinoshita, J.H.; Sharpless, N.E. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. J. Med. Chem., 1985, 28 (7), 841-849.
    • (1985) J. Med. Chem. , vol.28 , Issue.7 , pp. 841-849
    • Kador, P.F.1    Kinoshita, J.H.2    Sharpless, N.E.3
  • 213
    • 65649103414 scopus 로고    scopus 로고
    • Aldose reductase enzyme and its implication tomajor health problems of the 21st century
    • Alexiou, P.; Pegklidou, K.; Chatzopoulou, M.; Nicolaou, I.; Demopoulos, V.J. Aldose reductase enzyme and its implication tomajor health problems of the 21st century. Curr. Med. Chem., 2009, 16 (6), 734-752.
    • (2009) Curr. Med. Chem. , vol.16 , Issue.6 , pp. 734-752
    • Alexiou, P.1    Pegklidou, K.2    Chatzopoulou, M.3    Nicolaou, I.4    Demopoulos, V.J.5
  • 214
    • 0000930578 scopus 로고
    • Isolation and properties of lens aldose reductase
    • Hayman, S.; Kinoshita, J.H. Isolation and properties of lens aldose reductase. J. Biol. Chem., 1965, 240 (2), 877-882.
    • (1965) J. Biol. Chem. , vol.240 , Issue.2 , pp. 877-882
    • Hayman, S.1    Kinoshita, J.H.2
  • 215
    • 0015887637 scopus 로고
    • Polyol accumulation in galactosemic and diabetic rats: Control by an aldose reductase inhaibitor
    • Dvornik, D.; Simard-Duquesne, N.; Keami, M.; Sestanj, K. Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhaibitor. Science, 1973, 182 (4117), 1146-1148.
    • (1973) Science , vol.182 , Issue.4117 , pp. 1146-1148
    • Dvornik, D.1    Simard-Duquesne, N.2    Keami, M.3    Sestanj, K.4
  • 216
    • 0021323690 scopus 로고
    • N-[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl] -N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor
    • Sestanj, K.; Bellini, F.; Fung, S.; Abraham, N.; Treasurywala, A.; Humber, L.; Simard-Duquesne, N.; Dvornik, D. N-[5-(Trifluoromethyl)-6-methoxy-1- naphthalenyl]thioxomethyl]-N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor. J. Med. Chem., 1984, 27 (3), 255-256.
    • (1984) J. Med. Chem. , vol.27 , Issue.3 , pp. 255-256
    • Sestanj, K.1    Bellini, F.2    Fung, S.3    Abraham, N.4    Treasurywala, A.5    Humber, L.6    Simard-Duquesne, N.7    Dvornik, D.8
  • 217
    • 0020526445 scopus 로고
    • Effect of a new aldose reductase inhibitor (E)-3-carboxymethyl-5-[(2E)- methyl-3-phenylpropenyl-idene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats
    • Kikkawa, R.; Hatanaka, I.; Yasuda, H.; Kobayashi, N.; Shigeta, Y.; Terashima, H.; Morimura, T.; Tsuboshima, M. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenyl-idene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia, 1983, 24 (4), 290-292.
    • (1983) Diabetologia , vol.24 , Issue.4 , pp. 290-292
    • Kikkawa, R.1    Hatanaka, I.2    Yasuda, H.3    Kobayashi, N.4    Shigeta, Y.5    Terashima, H.6    Morimura, T.7    Tsuboshima, M.8
  • 218
    • 0025967888 scopus 로고
    • Novel, potent aldose reductase inhibitors: 3, 4-dihydro-4-oxo-3-[[5- (trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners
    • Mylari, B.L.; Larson, E.R.; Beyer, T.A.; Zembrowski, W.J.; Aldinger, C.E.; Dee, M.F.; Siegel, T.W.; Singleton, D.H. Novel, potent aldose reductase inhibitors: 3, 4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners. J. Med. Chem., 1991, 34 (1), 108-122.
    • (1991) J. Med. Chem. , vol.34 , Issue.1 , pp. 108-122
    • Mylari, B.L.1    Larson, E.R.2    Beyer, T.A.3    Zembrowski, W.J.4    Aldinger, C.E.5    Dee, M.F.6    Siegel, T.W.7    Singleton, D.H.8
  • 219
    • 0025956755 scopus 로고
    • Characterization of a novel aldose reductase inhibitor FR74366 and its effects on diabetic cataract and neuropathy in the rat
    • Ao, S.; Shingu, Y.; Kikuchi, C.; Takano, Y.; Nomura, K.; Fujiwara, T.; Ohkubo, Y.; Notsu, Y.; Yamaguchi, I. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat. Metabolism., 1991, 40 (1), 77-87.
    • (1991) Metabolism. , vol.40 , Issue.1 , pp. 77-87
    • Ao, S.1    Shingu, Y.2    Kikuchi, C.3    Takano, Y.4    Nomura, K.5    Fujiwara, T.6    Ohkubo, Y.7    Notsu, Y.8    Yamaguchi, I.9
  • 220
    • 0021814782 scopus 로고
    • Properties of ICI 128, 436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat
    • Stribling, D.; Mirrlees, D.J.; Harrison, H.E.; Earl, D.C. Properties of ICI 128, 436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. Metabolism., 1985, 34 (4), 336-344.
    • (1985) Metabolism. , vol.34 , Issue.4 , pp. 336-344
    • Stribling, D.1    Mirrlees, D.J.2    Harrison, H.E.3    Earl, D.C.4
  • 221
    • 20944432343 scopus 로고    scopus 로고
    • Discovery of 3-[(4, 5, 7-trifluorobenzothiazol-2-yl)methyl]indole-N- acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications
    • Van Zandt, M.C.; Jones, M.L.; Gunn, D.E.; Geraci, L.S.; Jones, J.H.; Sawicki, D.R.; Sredy, J.; Jacot, J.L.; DiCioccio, A.T.; Petrova, T.; Mitschler, A.; Podjarny, A.D. Discovery of 3-[(4, 5, 7-trifluorobenzothiazol-2-yl)methyl] indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J. Med. Chem., 2005, 48 (9), 3141-3152.
    • (2005) J. Med. Chem. , vol.48 , Issue.9 , pp. 3141-3152
    • Van Zandt, M.C.1    Jones, M.L.2    Gunn, D.E.3    Geraci, L.S.4    Jones, J.H.5    Sawicki, D.R.6    Sredy, J.7    Jacot, J.L.8    Dicioccio, A.T.9    Petrova, T.10    Mitschler, A.11    Podjarny, A.D.12
  • 223
    • 0019287523 scopus 로고
    • Synthesis and Aldose Reductase Inhibitory Activity of 7-Sulfamoylxanthone-2-carboxylic Acids
    • Pfister, J.R.; Wymann, W.E.; Mahoney, J.M.; Waterbury, L.D. Synthesis and Aldose Reductase Inhibitory Activity of 7-Sulfamoylxanthone-2-carboxylic Acids. J. Med. Chem., 1980, 23 (11), 1264-1267.
    • (1980) J. Med. Chem. , vol.23 , Issue.11 , pp. 1264-1267
    • Pfister, J.R.1    Wymann, W.E.2    Mahoney, J.M.3    Waterbury, L.D.4
  • 224
    • 0023267954 scopus 로고
    • Novel Inhibitors of Rat Lens Aldose Reductase: N-[[(Substituted amino) phenyl]sulfonyl]glycines
    • Mayfield, CA.; DeRuiter, J. Novel Inhibitors of Rat Lens Aldose Reductase: N-[[(Substituted amino) phenyl]sulfonyl]glycines. J. Med. Chem., 1987, 30 (9), 1595-1598.
    • (1987) J. Med. Chem. , vol.30 , Issue.9 , pp. 1595-1598
    • Mayfield, C.A.1    Deruiter, J.2
  • 225
    • 78649855244 scopus 로고    scopus 로고
    • Acetic Acid Derivatives of 3, 4-Dihydro-2H-1 2, 4-benzothiadiazine 1, 1-Dioxide as a Novel Class of Potent Aldose Reductase Inhibitors
    • Chen, X.; Zhu, C; Guo, F.; Qiu, X.; Yang, Y.; Zhang, S.; He, M.; Parveen, S.; Jing, C; Li, Y; Ma, B. Acetic Acid Derivatives of 3, 4-Dihydro-2H-1, 2, 4-benzothiadiazine 1, 1-Dioxide as a Novel Class of Potent Aldose Reductase Inhibitors. J. Med. Chem., 2010, 53 (23), 8330-8344.
    • (2010) J. Med. Chem. , vol.53 , Issue.23 , pp. 8330-8344
    • Chen, X.1    Zhu, C.2    Guo, F.3    Qiu, X.4    Yang, Y.5    Zhang, S.6    He, M.7    Parveen, S.8    Jing, C.9    Li, Y.10    Ma, B.11
  • 226
    • 79953226757 scopus 로고    scopus 로고
    • Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold
    • Chen, X.; Yang, Y; Ma, B.; Zhang, S.; He, M.; Gui, D.; Hussain, S.; Jing, C; Zhu, C; Yu, Q.; Liu, Y Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold. Eur. J. Med. Chem., 2011, 46 (5), 1536-1544.
    • (2011) Eur. J. Med. Chem. , vol.46 , Issue.5 , pp. 1536-1544
    • Chen, X.1    Yang, Y.2    Ma, B.3    Zhang, S.4    He, M.5    Gui, D.6    Hussain, S.7    Jing, C.8    Zhu, C.9    Yu, Q.10    Liu, Y.11
  • 227
    • 80655136956 scopus 로고    scopus 로고
    • 1, 2-Benzothiazine 1, 1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase
    • Chen, X.; Zhang, S.; Yang, Y; Hussain, S.; He, M.; Gui, D.; Ma, B.; Jing, C; Qiao, Z.; Zhu, C; Yu, Q. 1, 2-Benzothiazine 1, 1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase. Bioorg. Med. Chem., 2011, 19 (23), 7262-7269.
    • (2011) Bioorg. Med. Chem. , vol.19 , Issue.23 , pp. 7262-7269
    • Chen, X.1    Zhang, S.2    Yang, Y.3    Hussain, S.4    He, M.5    Gui, D.6    Ma, B.7    Jing, C.8    Qiao, Z.9    Zhu, C.10    Yu, Q.11
  • 228
    • 0023189440 scopus 로고
    • Development of potent aldose reductase Inhibitors having a hydantoin structure
    • Miwa, I; Hirano, M.; Inagaki, K.; Belbeoch, C; Okuda, A.J. Development of potent aldose reductase Inhibitors having a hydantoin structure. Biochem. Pharmacol, 1987, 36 (17), 2789-2794.
    • (1987) Biochem. Pharmacol , vol.36 , Issue.17 , pp. 2789-2794
    • Miwa, I.1    Hirano, M.2    Inagaki, K.3    Belbeoch, C.4    Okuda, A.J.5
  • 229
    • 0025362393 scopus 로고
    • Vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure
    • Miwa, I; Hirano, M.; Kanbara, M.; Okuda, J. In vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure. Biochem. Pharmacol, 1990, 40 (2), 303-307.
    • (1990) Biochem. Pharmacol , vol.40 , Issue.2 , pp. 303-307
    • Miwa, I.1    Hirano, M.2    Kanbara, M.3    Okuda, J.4
  • 230
    • 0025737815 scopus 로고
    • Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil
    • Kato, K.; Nakayama, K.; Mizota, M.; Miwa, I; Okuda, J. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil. Chem. Pharm. Bull, 1991, 39 (6), 1540-1545.
    • (1991) Chem. Pharm. Bull , vol.39 , Issue.6 , pp. 1540-1545
    • Kato, K.1    Nakayama, K.2    Mizota, M.3    Miwa, I.4    Okuda, J.5
  • 231
    • 0026026047 scopus 로고
    • Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats
    • Kato, K.; Nakayama, K.; Ohta, M.; Murakami, N; Murakami, K.; Mizota, M.; Miwa, I; Okuda, J. Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats. Eur. J. Pharmacol, 1991, 193 (2), 185-191.
    • (1991) Eur. J. Pharmacol , vol.193 , Issue.2 , pp. 185-191
    • Kato, K.1    Nakayama, K.2    Ohta, M.3    Murakami, N.4    Murakami, K.5    Mizota, M.6    Miwa, I.7    Okuda, J.8
  • 234
    • 0033867728 scopus 로고    scopus 로고
    • Synthesis and aldose reductase inhibitory activities of novel Nnitromethylsulfonanilide derivatives
    • Inoue, J.; Cui, Y; Sakai, O.; Nakamura, Y; Kogiso, H.; Kador, P. Synthesis and aldose reductase inhibitory activities of novel Nnitromethylsulfonanilide derivatives. Bioorg. Med. Chem., 2000, 8 (8), 2167-2173.
    • (2000) Bioorg. Med. Chem. , vol.8 , Issue.8 , pp. 2167-2173
    • Inoue, J.1    Cui, Y.2    Sakai, O.3    Nakamura, Y.4    Kogiso, H.5    Kador, P.6
  • 236
    • 26444477394 scopus 로고    scopus 로고
    • A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and Congeners
    • Mylari, B.L.; Armento, S.J.; Beebe, D.A.; Conn, E.L.; Coutcher, J.B.; Dina, M.S.; O'Gorman, M.T.; Linhares, M.C.; Martin, W.H.; Oates, P.J.; Tess, D.A.; Withbroe, G.J.; Zembrowski, W.J. A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3- one and Congeners. J. Med. Chem., 2005, 48 (20), 6326-6339.
    • (2005) J. Med. Chem. , vol.48 , Issue.20 , pp. 6326-6339
    • Mylari, B.L.1    Armento, S.J.2    Beebe, D.A.3    Conn, E.L.4    Coutcher, J.B.5    Dina, M.S.6    O'Gorman, M.T.7    Linhares, M.C.8    Martin, W.H.9    Oates, P.J.10    Tess, D.A.11    Withbroe, G.J.12    Zembrowski, W.J.13
  • 237
    • 41649105654 scopus 로고    scopus 로고
    • Design and synthesis of N-3, 5-difluoro-4-hydroxyphenyl) benzenesulfonamides as aldose reductase inhibitors
    • Alexiou, P.; Nicolaou, I; Stefek, M.; Kristl, A.; Demopoulos, V.J. Design and synthesis of N-(3, 5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors. Bioorg. Med. Chem., 2008, 16 (7), 3926-3932.
    • (2008) Bioorg. Med. Chem. , vol.16 , Issue.7 , pp. 3926-3932
    • Alexiou, P.1    Nicolaou, I.2    Stefek, M.3    Kristl, A.4    Demopoulos, V.J.5
  • 238
    • 42749087181 scopus 로고    scopus 로고
    • Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of a-glucosidase inhibitors
    • Bharatham, K.; Bharatham, N; Park, K.H.; Lee, K.W. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of a-glucosidase inhibitors. J. Mol Graph. Model, 2008, 26 (8), 1202-1212.
    • (2008) J. Mol Graph. Model , vol.26 , Issue.8 , pp. 1202-1212
    • Bharatham, K.1    Bharatham, N.2    Park, K.H.3    Lee, K.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.